Apyx Medical Corp (APYX) Gross margin 2016–2025
Apyx Medical Corp (APYX) gross margin by fiscal year — reported gross profit divided by reported revenue.
62.5%FY2025 · since FY2016: 58.0% → 62.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 62.5% | +1.5 pp |
| FY2024 | 61.0% | -3.5 pp |
| FY2023 | 64.5% | -1.0 pp |
| FY2022 | 65.4% | -3.8 pp |
| FY2021 | 69.3% | +6.1 pp |
| FY2020 | 63.2% | -4.5 pp |
| FY2019 | 67.6% | +2.4 pp |
| FY2018 | 65.2% | -2.8 pp |
| FY2017 | 68.0% | +10.0 pp |
| FY2016 | 58.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More APYX financial trends
APYX RevenueAPYX Net incomeAPYX Net marginAPYX Gross profitAPYX Operating incomeAPYX Operating marginAPYX Operating cash flowAPYX Free cash flowAPYX Capital expendituresAPYX Return on equityAPYX Stock buybacksAPYX Dividends paidAPYX Total assetsAPYX Total liabilitiesAPYX Shareholders’ equityAPYX overview →